However, only two out of these three studies performed subgroup analysis regarding the presence or absence of T2DM, and both studies did not report any significant difference between the two groups in terms of the efficacy of SGLT2 inhibitors. Here, SLC5A2 is linked to type 2 diabetes mellitus.